Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP516144.RA7ri_kxo1dpImuAVTmgdK7PZhEVgfTSJuRXyq9FwLPGE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP516144.RA7ri_kxo1dpImuAVTmgdK7PZhEVgfTSJuRXyq9FwLPGE130_assertion type Assertion NP516144.RA7ri_kxo1dpImuAVTmgdK7PZhEVgfTSJuRXyq9FwLPGE130_head.
- NP516144.RA7ri_kxo1dpImuAVTmgdK7PZhEVgfTSJuRXyq9FwLPGE130_assertion description "[Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516144.RA7ri_kxo1dpImuAVTmgdK7PZhEVgfTSJuRXyq9FwLPGE130_provenance.
- NP516144.RA7ri_kxo1dpImuAVTmgdK7PZhEVgfTSJuRXyq9FwLPGE130_assertion evidence source_evidence_literature NP516144.RA7ri_kxo1dpImuAVTmgdK7PZhEVgfTSJuRXyq9FwLPGE130_provenance.
- NP516144.RA7ri_kxo1dpImuAVTmgdK7PZhEVgfTSJuRXyq9FwLPGE130_assertion SIO_000772 19148493 NP516144.RA7ri_kxo1dpImuAVTmgdK7PZhEVgfTSJuRXyq9FwLPGE130_provenance.
- NP516144.RA7ri_kxo1dpImuAVTmgdK7PZhEVgfTSJuRXyq9FwLPGE130_assertion wasDerivedFrom befree-20150227 NP516144.RA7ri_kxo1dpImuAVTmgdK7PZhEVgfTSJuRXyq9FwLPGE130_provenance.
- NP516144.RA7ri_kxo1dpImuAVTmgdK7PZhEVgfTSJuRXyq9FwLPGE130_assertion wasGeneratedBy ECO_0000203 NP516144.RA7ri_kxo1dpImuAVTmgdK7PZhEVgfTSJuRXyq9FwLPGE130_provenance.